Monarch eTNS System
Pediatric ADHD
ApprovedActive
Key Facts
About NeuroSigma
NeuroSigma is a commercial-stage medical device company pioneering external trigeminal nerve stimulation (eTNS) for neuromodulation. Its flagship Monarch eTNS System holds FDA clearance for pediatric ADHD as a non-invasive, non-pharmacological treatment, representing a first-in-class device. The company is targeting large neurological markets, including epilepsy and depression, with its patented platform. Backed by clinical data from multiple trials and an extensive patent portfolio, NeuroSigma aims to provide accessible, evidence-based neurotherapeutics.
View full company profileTherapeutic Areas
Other Pediatric ADHD Drugs
| Drug | Company | Phase |
|---|---|---|
| Child ADHD Study | Sun Valley Research Center | Not Disclosed |
| EndeavorRx® | PureTech Health | Approved |